A Unique Approach: Biomimetic Graphdiyne-Based Nanoplatform to Treat Prostate Cancer by Combining Cuproptosis and Enhanced Chemodynamic Therapy
DOI: https://doi.org/10.2147/ijn.s455355
IF: 7.033
2024-05-02
International Journal of Nanomedicine
Abstract:Wenjie Xie, 1, 2, &ast Yixun Zhang, 1, 2, &ast Qianfeng Xu, 1, 2, &ast Guowei Zhong, 1, 2 Jundong Lin, 2, 3 Huichan He, 3 Qiuling Du, 2 Huijing Tan, 1, 2 Muqi Chen, 1, 2 Zhenjie Wu, 1– 3 Yulin Deng, 1, 2 Zhaodong Han, 1– 3 Jianming Lu, 1, 2, 4 Jianheng Ye, 1, 2, 4 Fen Zou, 1, 2 Yangjia Zhuo, 1, 2 Weide Zhong 1– 4 1 Department of Urology, The Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, People's Republic of China; 2 Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, People's Republic of China; 3 Urology Key Laboratory of Guangdong Province, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510230, People's Republic of China; 4 State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa, Macau, 999078, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yangjia Zhuo; WeideZhong, Email ; Purpose: Current treatment approaches for Prostate cancer (PCa) often come with debilitating side effects and limited therapeutic outcomes. There is urgent need for an alternative effective and safe treatment for PCa. Methods: We developed a nanoplatform to target prostate cancer cells based on graphdiyne (GDY) and a copper-based metal-organic framework (GDY-CuMOF), that carries the chemotherapy drug doxorubicin (DOX) for cancer treatment. Moreover, to provide GDY-CuMOF@DOX with homotypic targeting capability, we coated the PCa cell membrane (DU145 cell membrane, DCM) onto the surface of GDY-CuMOF@DOX, thus obtaining a biomimetic nanoplatform (DCM@GDY-CuMOF@DOX). The nanoplatform was characterized by using transmission electron microscope, atomic force microscope, X-ray diffraction, etc. Drug release behavior, antitumor effects in vivo and in vitro, and biosafety of the nanoplatform were evaluated. Results: We found that GDY-CuMOF exhibited a remarkable capability to load DOX mainly through π-conjugation and pore adsorption, and it responsively released DOX and generated Cu + in the presence of glutathione (GSH). In vivo experiments demonstrated that this nanoplatform exhibits remarkable cell-killing efficiency by generating lethal reactive oxygen species (ROS) and mediating cuproptosis. In addition, DCM@GDY-CuMOF@DOX effectively suppresses tumor growth in vivo without causing any apparent side effects. Conclusion: The constructed DCM@GDY-CuMOF@DOX nanoplatform integrates tumor targeting, drug-responsive release and combination with cuproptosis and chemodynamic therapy, offering insights for further biomedical research on efficient PCa treatment. Keywords: graphdiyne, biomimetic nanoplatform, cuproptosis, chemotherapy, prostate cancer Graphical Prostate cancer (PCa) is caused by one of the most common malignant tumors resulting in high morbidity and mortality in males. 1 Most patients with PCa are already at an advanced stage of the tumor at the time of diagnosis. 2 Endocrine therapy with androgen deprivation is the current standard of care therapy. Although androgen deprivation therapy has beneficial effects on advanced-stage PCa, this endocrine therapy inevitably promotes the emergence of castration-resistant prostate cancer (CRPC), which can accelerate the tumor metastasis, render chemotherapy, endocrine therapy, or immunotherapy ineffective and ultimately shorten patient survival time. 3–6 Considering the limitations of the clinical treatment for PCa, there is urgent need for an alternative effective and safe treatment for PCa. Copper (Cu) is an essential trace element present in all organisms and plays a crucial role in bioactivity. In biological systems, Cu is involved in many redox reactions as a cofactor for various enzymes, shifting between two oxidation states (Cu 2+ and Cu + ). 7 Bioavailable Cu serves as a structural component in many proteins and ligands. 8 Organisms maintain the concentration of Cu ions through an inherently sophisticated regulation system ensuring that free Cu ions are usually less than one atom per cell. 9 Excessive Cu levels may disrupt homeostatic mechanisms, resulting in severe systemic toxicity. -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology